CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for WaferGen Bio-systems, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

WaferGen Bio-systems, Inc.
34700 Campus Drive
Phone: (510) 651-4450p:510 651-4450 Fremont, CA  94555-3612  United States Ticker: WGBS WGBS

This company was Merged or Acquired on 3/1/2017.
This company ceased filing statements with the SEC on 3/13/2017.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201612/31/2015YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Ivan D.Trifunovich 52 5/11/2015 3/8/2012
President, Chief Executive Officer, Director RollandCarlson 61 5/11/2015 5/11/2015
Chief Financial Officer, Treasurer, Secretary Michael P.Henighan 62 12/1/2014 8/25/2014
5 additional Officers and Directors records available in full report.

Business Names
Business Name
WaferGen Biosystems Europe S.a.r.l.
Wafergen, Inc.
WGBS

General Information
Number of Employees: 28 (As of 12/31/2013)
Outstanding Shares: 3,785,545 (As of 11/29/2016)
Shareholders: 365
Stock Exchange: NASD
Federal Tax Id: 900416683


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 5, 2021